ARK Genomic Revolution ETF vs BlackBerry Limited — how do they compare? ARK Genomic Revolution ETF trades at $44.5, while BlackBerry Limited trades at $9.18 (market cap $5.18B). The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, BlackBerry Limited nearer its low. Which is the better fit depends on your goals.
| ARKG | BB | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $12.81 |
52-Week Low | $24.02 | $3.15 |
Market Cap | — | $5.18B |
Enterprise Value | — | $5.05B |
Signals from Pluang's Aura AI — not financial advice
ARKG, the ARK Genomic Revolution ETF, trades at $43.04, up 6.06% in the past 24 hours, with a bullish technical signal from moving averages and ADX indicators. The ETF focuses on small- and mid-cap biotech stocks, with its top 10 holdings comprising 59% of the portfolio and a long-term EPS growth rate of 10.7%. Recent news highlights its recovery from a 15% correction, with support emerging at key levels.
The outlook for ARKG is positive, driven by biotech sector tailwinds including a friendlier FDA, strong M&A activity, and AI-driven drug discovery. Risks include high concentration in volatile biotech names and sensitivity to broader market sell-offs. Investors should weigh the growth potential against the inherent volatility of genomics investments.
No Aura AI signal available yet.
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →BlackBerry Limited provides intelligent security software solutions. The Company offers artificial intelligence and machine learning for cybersecurity, safety, and data privacy solutions, as well as endpoint security and management, encryption, and embedded systems. BlackBerry serves governments and enterprise sectors worldwide.
Read more on BB →